Universal solid-phase hybridization apparatus
CA 2282296 A1 · Owner: Saigene Corporation · Inventors: U'Ren, Jack
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of determining the presence of a nucleic acid analyte from a sample comprising binding a biotinylated capture oligonucleotide to a solid phase noncovalently coated with streptavidin or an avidin derivative. The capture oligonucleotide is contacted with and selectively hybridized to under , stringent hybridization conditions a nucleic acid analyte to form a , detectable hybridization complex.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 19, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 19, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 19, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.